189 related articles for article (PubMed ID: 23861742)
1. Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination.
Parra M; Liu X; Derrick SC; Yang A; Tian J; Kolibab K; Kumar S; Morris SL
PLoS One; 2013; 8(7):e66115. PubMed ID: 23861742
[TBL] [Abstract][Full Text] [Related]
2. Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria
Imai T; Suzue K; Ngo-Thanh H; Ono S; Orita W; Suzuki H; Shimokawa C; Olia A; Obi S; Taniguchi T; Ishida H; Van Kaer L; Murata S; Tanaka K; Hisaeda H
Front Immunol; 2019; 10():2207. PubMed ID: 31608052
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.
Matsumoto S; Yukitake H; Kanbara H; Yamada H; Kitamura A; Yamada T
Vaccine; 2000 Nov; 19(7-8):779-87. PubMed ID: 11115699
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium yoelii blood-stage primes macrophage-mediated innate immune response through modulation of toll-like receptor signalling.
Fu Y; Ding Y; Zhou T; Fu X; Xu W
Malar J; 2012 Apr; 11():104. PubMed ID: 22463100
[TBL] [Abstract][Full Text] [Related]
5. Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice.
Parra M; Derrick SC; Yang A; Tian J; Kolibab K; Oakley M; Perera LP; Jacobs WR; Kumar S; Morris SL
PLoS One; 2011; 6(12):e28164. PubMed ID: 22205939
[TBL] [Abstract][Full Text] [Related]
6. Resistance of regulatory T cells to glucocorticoid-induced [corrected] TNFR family-related protein (GITR) during Plasmodium yoelii infection.
Hisaeda H; Hamano S; Mitoma-Obata C; Tetsutani K; Imai T; Waldmann H; Himeno K; Yasutomo K
Eur J Immunol; 2005 Dec; 35(12):3516-24. PubMed ID: 16304635
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.
Belnoue E; Voza T; Costa FT; Grüner AC; Mauduit M; Rosa DS; Depinay N; Kayibanda M; Vigário AM; Mazier D; Snounou G; Sinnis P; Rénia L
J Immunol; 2008 Dec; 181(12):8552-8. PubMed ID: 19050274
[TBL] [Abstract][Full Text] [Related]
8. Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.
Peng X; Keitany GJ; Vignali M; Chen L; Gibson C; Choi K; Huang F; Wang R
J Immunol; 2014 Aug; 193(3):1268-77. PubMed ID: 24958899
[TBL] [Abstract][Full Text] [Related]
9. Potential and Limitations of Cross-Protective Vaccine against Malaria by Blood-Stage Naturally Attenuated Parasite.
Imai T; Suzue K; Ngo-Thanh H; Shimokawa C; Hisaeda H
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32664476
[TBL] [Abstract][Full Text] [Related]
10. Memory CD73+IgM+ B cells protect against Plasmodium yoelii infection and express Granzyme B.
Parra M; Weitner M; Yang A; Akue A; Liu X; Schmidt T; Allman WR; Akkoyunlu M; Derrick SC
PLoS One; 2020; 15(9):e0238493. PubMed ID: 32886698
[TBL] [Abstract][Full Text] [Related]
11. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
Hirunpetcharat C; Vukovic P; Liu XQ; Kaslow DC; Miller LH; Good MF
J Immunol; 1999 Jun; 162(12):7309-14. PubMed ID: 10358180
[TBL] [Abstract][Full Text] [Related]
12. CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii.
Doll KL; Butler NS; Harty JT
Vaccine; 2014 Jan; 32(4):483-91. PubMed ID: 24321740
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein.
Parra M; Liu X; Derrick SC; Yang A; Molina-Cruz A; Barillas-Mury C; Zheng H; Thao Pham P; Sedegah M; Belmonte A; Litilit DD; Waldmann TA; Kumar S; Morris SL; Perera LP
PLoS One; 2015; 10(10):e0141141. PubMed ID: 26505634
[TBL] [Abstract][Full Text] [Related]
14. Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen.
Hwang SA; Welsh KJ; Boyd S; Kruzel ML; Actor JK
Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S90-5. PubMed ID: 22088320
[TBL] [Abstract][Full Text] [Related]
15. CHO expressed recombinant human lactoferrin as an adjuvant for BCG.
Hwang SA; Kruzel ML; Actor JK
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):452-68. PubMed ID: 26315722
[TBL] [Abstract][Full Text] [Related]
16. Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts.
Shear HL; Srinivasan R; Nolan T; Ng C
J Immunol; 1989 Sep; 143(6):2038-44. PubMed ID: 2506274
[TBL] [Abstract][Full Text] [Related]
17. The Toll-Like Receptor 2 agonist PEG-Pam
Ernest M; Hunja C; Arakura Y; Haraga Y; Abkallo HM; Zeng W; Jackson DC; Chua B; Culleton R
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):451-458. PubMed ID: 30396012
[TBL] [Abstract][Full Text] [Related]
18. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
Matsumoto S; Yukitake H; Kanbara H; Yamada T
J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
[TBL] [Abstract][Full Text] [Related]
20. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
